Jiangxi Synergy Pharmaceutical Co Ltd (300636) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥65.40 Million ≈ $9.57 Million USD) by net assets (CN¥2.38 Billion ≈ $347.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangxi Synergy Pharmaceutical Co Ltd (300636) net asset quality to measure how much of total assets are equity-financed.
Jiangxi Synergy Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Jiangxi Synergy Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Jiangxi Synergy Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Jiangxi Synergy Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangxi Synergy Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Baotou Dongbao Bio-Tech Co Ltd
SHE:300239
|
0.005x |
|
Issta Lines Ltd
TA:ISTA
|
0.034x |
|
CN EVERBRIGHT WATER HD 1
F:BIU2
|
N/A |
|
Benitec Biopharma Ltd ADR
NASDAQ:BNTC
|
-0.020x |
|
Panin Financial Tbk
JK:PNLF
|
0.014x |
|
Fujian Minfa Aluminium Co Ltd
SHE:002578
|
-0.035x |
|
China Chippacking Technology Co. Ltd. A
SHG:688216
|
N/A |
|
THONBURI HEALTHCARE GRO-NVDR
BK:THG-R
|
N/A |
Annual Cash Flow Conversion Efficiency for Jiangxi Synergy Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Jiangxi Synergy Pharmaceutical Co Ltd (300636) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.37 Billion ≈ $346.11 Million |
CN¥202.07 Million ≈ $29.57 Million |
0.085x | -30.84% |
| 2024-12-31 | CN¥2.31 Billion ≈ $337.84 Million |
CN¥285.19 Million ≈ $41.73 Million |
0.124x | +67.95% |
| 2023-12-31 | CN¥2.23 Billion ≈ $325.80 Million |
CN¥163.75 Million ≈ $23.96 Million |
0.074x | -50.48% |
| 2022-12-31 | CN¥1.32 Billion ≈ $193.11 Million |
CN¥196.00 Million ≈ $28.68 Million |
0.149x | +0.43% |
| 2021-12-31 | CN¥888.11 Million ≈ $129.96 Million |
CN¥131.34 Million ≈ $19.22 Million |
0.148x | +50.81% |
| 2020-12-31 | CN¥816.50 Million ≈ $119.48 Million |
CN¥80.07 Million ≈ $11.72 Million |
0.098x | +344.98% |
| 2019-12-31 | CN¥706.31 Million ≈ $103.36 Million |
CN¥-28.27 Million ≈ $-4.14 Million |
-0.040x | -135.16% |
| 2018-12-31 | CN¥658.16 Million ≈ $96.31 Million |
CN¥74.93 Million ≈ $10.96 Million |
0.114x | +113.00% |
| 2017-12-31 | CN¥637.10 Million ≈ $93.23 Million |
CN¥34.05 Million ≈ $4.98 Million |
0.053x | -73.06% |
| 2016-12-31 | CN¥304.66 Million ≈ $44.58 Million |
CN¥60.45 Million ≈ $8.85 Million |
0.198x | -38.38% |
| 2015-12-31 | CN¥246.66 Million ≈ $36.09 Million |
CN¥79.42 Million ≈ $11.62 Million |
0.322x | -41.08% |
| 2014-12-31 | CN¥118.02 Million ≈ $17.27 Million |
CN¥64.50 Million ≈ $9.44 Million |
0.547x | +198.77% |
| 2013-12-31 | CN¥78.82 Million ≈ $11.53 Million |
CN¥14.42 Million ≈ $2.11 Million |
0.183x | +406.36% |
| 2012-12-31 | CN¥45.51 Million ≈ $6.66 Million |
CN¥-2.72 Million ≈ $-397.62K |
-0.060x | -- |
About Jiangxi Synergy Pharmaceutical Co Ltd
Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepr… Read more